Related Experiment Video
Updated: Aug 9, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
[Breast cancer detection and medicalization of public health]
1Ecole Nationale de la Santé Publique, Département d'évaluation et de gestion des risques liés à l'environnement et au système de soins, Rennes Avenue Professeur Léon-Bernard, CS 74312, F-35043 Rennes, France.
Abstract:
The aim of reducing breast cancer mortality announced in the report on health in France published in 1994 strongly implicated the promotion of screening and early surgical treatment. However, this mortality has not evolved significantly in France, although more and more cancers have been found and operated upon. The increased prevalence rates of histological diagnoses of breast cancer obtained from the studies of autopsies published has shown that the screening has discovered non-terminal, benign cancers. It has been estimated that 120 of the surgical operations conducted per day in France in 1999 have been carried out to remove non-terminal, benign cancers. Public health has an ethical responsibility to face in terms of the allocation of resources and must remain vigilant in order to avoid excessive screening and unnecessary interventions.
Related Concept Videos
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer Prevention
Some...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Cancer Survival Analysis

